SCHEMBL12726005

SCHEMBL12726005

C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](OC(=O)N2Cc3cccc(Cl)c3C2)CN1C(=O)[C@@H](N)C1CCCCC1)C(=O)NS(=O)(=O)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12726004 0.93 — —
SCHEMBL12765225 0.91 ELANE (0.40) —
SCHEMBL3761797 0.90 CYP3A4 (0.45) —
SCHEMBL1635117 0.90 CYP3A4 (0.45) —
SCHEMBL1635115 0.90 CYP3A4 (0.45) —
SCHEMBL3761800 0.90 CYP3A4 (0.45) —
SCHEMBL12726003 0.90 CYP3A4 (0.50) —
SCHEMBL12726025 0.89 ADORA3 (0.39) —
SCHEMBL8117106 0.88 CFD (0.43) —
SCHEMBL12765143 0.86 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932277-B2 Peptide inhibitors of hepatitis C virus replication INTERMUNE, INC. (US) 2011-04-26 — — US disclosed
US-20090297476-A1 NOVEL PEPTIDE INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-12-03 — — US disclosed
Send feedback